News
Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...
StockStory.org on MSN17h
LLY Q1 Earnings Call: Revenue Beats Expectations, Profit Guidance Trimmed Amid Price PressuresGlobal pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback